SPYD241220C48000
- 0.10
- -0.05-33.33%
Spdr Series Trust Spdr Portfolio S&P 500 High Dividend Etf Newsroom
Russia's 'uranium restrictions', nuclear power stocks surge, hedge fund king Griffin provides assistance: I have invested in nuclear power, this is the future
Russia's restriction on the export of concentrated uranium to the usa may pose supply risks to the utilities operating american reactors, which supply nearly one-fifth of the usa's electrical utilities. Last month, Griffin participated in a $0.5 billion financing for the small modular reactor (SMR) developer X-Energy, led by amazon.
Overweight-rated Financial Stocks, as Group's Outlook Looks Attractive - MS
Morgan Stanley Is Moving Its Rating On U.S. Stocks To Overweight, And Targeting 6,500 At The End Of 2025, Compared To A June 2025 Target Of 5,400; Its New Base Target Is Above Its Previous "Bull" Scenario, Which Was 6,350. Now It Says The S&P Could...
Wall Street Banks Said to Partner With BlackRock's Aladdin for Bond Price Data
Entergy Analyst Ratings
26 Analysts Assess Gilead Sciences: What You Need To Know
Gilead Sciences Analyst Ratings
Morgan Stanley Prfd Series I Raises Dividend by 2.2% to $0.4072
Morgan Stanley Dep Sh 1/1000TH Fxd/Fltg Prfd Stk Series E Declares $0.4552 Dividend
Morgan Stanley Dep Shs Non-Cum Pfd Registered Shs Series A Dividend Declines by 10.4% to $0.3583
Wall Street's Banking Giants Load Up On Bitcoin, Ethereum ETFs: Here's What JPMorgan, Goldman Sachs And Morgan Stanley Hold
J.P. Morgan Sees Investment Banks' Post-election Momentum Continuing
The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.
Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.
Shares of Pharmaceutical and Healthcare Stocks Are Trading Lower. The Sector Has Been Under Pressure After President-elect Trump Nominated Robert F. Kennedy Jr. to Lead the HHS.
Sell-off of US vaccine stocks intensifies! Analyst: Little Kennedy brings uncertainty to the entire industry.
1. On Friday Eastern Time, vaccine manufacturers' stocks plummeted as Donald Trump selected vaccine skeptic Kennedy as Health Secretary, causing industry uncertainty. Moderna, Novavax, Pfizer, and other stock prices were all affected. 2. Analysts pointed out that Kennedy's anti-vaccine stance may weaken public trust in vaccines, leading to a decrease in the vaccination rate in the USA, increasing the risk of outbreaks of diseases such as measles and whooping cough.
Beyond The Numbers: 10 Analysts Discuss Morgan Stanley Stock
Large Pharmas, Biotechs Down as Industries Grapple With RFK Jr. at HHS
U.S. Pharma Is Largely Immune From 'MAHA' Impact: Wolfe
Gilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver Disease
Shares of Pharmaceutical Companies Are Trading Lower After President-elect Trump Nominated Robert F. Kennedy Jr. to Lead the HHS.